EGF and breast cancer: AP-1, in combination with EGF signalling, plays an essential role in regulating the transcriptional programme of SMAD and promotes TGF-β-induced invasiveness by cooperating with SMAD in the ΔNp63-expressing breast cancer cell lines (Sundqvist et al., 2020).